Anthropic lock-up expiration dates: the full release schedule
Anthropic's lock-up does not expire on one day. The final prospectus schedules the release of about 15.5 billion locked shares in 23 stages, from 19 Nov 2026 to 18 Nov 2027 at the latest. The next date is 15 Dec 2026, when up to 303 million shares become eligible for sale. Five of the dates are fixed on the calendar. The other eighteen are tied to results releases, and two of those also have a latest date: 17 May 2027 and 18 Nov 2027.
Eligible for sale is not a sale. Every release amount here is the prospectus's upper limit ("up to"), and holders decide whether to sell. This page lists dates and amounts from the filing; it does not say what the share price will do.
Anthropic lock-up release schedule: all 23 dates
The five fixed dates release up to 1.6 billion shares between them. The largest single releases are tied to results: up to 3.0 billion when the 180-day lock-up ends (row 12), up to 1.9 billion when the 365-day lock-up ends (row 23) and up to 1.7 billion after the FY2026 annual results (row 6).
| # | When | Up to, shares | ||||
|---|---|---|---|---|---|---|
| Fixed dates, counted from the prospectus date | ||||||
| 1 | 19 Nov 2026 · first trading day | 315M | ||||
| 2 | 15 Dec 2026 · day 27 | 303M | ||||
| 3 | 5 Jan 2027 · day 48 | 303M | ||||
| 4 | 19 Jan 2027 · day 62 | 353M | ||||
| 5 | 2 Feb 2027 · day 76 | 353M | ||||
| Tied to FY2026 results (release date not announced) | ||||||
| 6 | Second full trading day after FY2026 results | 1.7B | ||||
| 7 | 13 days after FY2026 results | 480M | ||||
| 8 | 27 days after FY2026 results | 480M | ||||
| 9 | 41 days after FY2026 results | 480M | ||||
| 10 | 55 days after FY2026 results | 480M | ||||
| 11 | 69 days after FY2026 results | 480M | ||||
| Tied to Q1 2027 results (release date not announced) | ||||||
| 12 | Second full trading day after Q1 2027 results, or after the close on 17 May 2027 if that comes first | 3.0B | ||||
| 13 | 34 days after Q1 2027 results | 447M | ||||
| 14 | 48 days after Q1 2027 results | 447M | ||||
| 15 | 62 days after Q1 2027 results | 447M | ||||
| 16 | 76 days after Q1 2027 results | 447M | ||||
| Tied to Q2 2027 results (release date not announced) | ||||||
| 17 | Second full trading day after Q2 2027 results | 558M | ||||
| 18 | 27 days after Q2 2027 results | 502M | ||||
| 19 | 41 days after Q2 2027 results | 502M | ||||
| 20 | 55 days after Q2 2027 results | 502M | ||||
| 21 | 69 days after Q2 2027 results | 502M | ||||
| 22 | 83 days after Q2 2027 results | 502M | ||||
| Tied to Q3 2027 results (release date not announced) | ||||||
| 23 | Second full trading day after Q3 2027 results, or after the close on 18 Nov 2027 if that comes first | 1.9B | ||||
From the table in "Shares Eligible for Future Sale" of the final prospectus. Amounts are the filing's rounded "up to" figures and it notes that totals may not add up exactly; the 23 rows sum to 15.5 billion. Which holders each row applies to is under who is locked up. "vs IPO shares" compares a release with the 980 million shares sold in the IPO. "xyz:ANT that day" is the perp's daily close on Hyperliquid and its change from the previous close, days in UTC, filled in once a dated release has passed; row 1 is the listing day itself. A price move on a release date is not evidence that holders sold.
Which dates are fixed and which depend on earnings
Rows 1 to 5 are counted from the prospectus date, 18 Nov 2026, and the filing prints their calendar dates: 19 Nov 2026, 15 Dec 2026, 5 Jan 2027, 19 Jan 2027, 2 Feb 2027. Rows 6 to 23 are tied to four results releases, and Anthropic had not announced a date for any of them when this page was checked.
- FY2026 results set rows 6 to 11: up to 1.7 billion on the second full trading day after the release, then up to 480 million on each of the 13th, 27th, 41st, 55th and 69th day after it.
- Q1 2027 results set rows 12 to 16. Row 12, up to 3.0 billion, comes on the second full trading day after the release or at the close of trading on 17 May 2027, day 180, whichever is earlier. Up to 447 million follows on each of the 34th, 48th, 62nd and 76th day after the release.
- Q2 2027 results set rows 17 to 22: up to 558 million, then up to 502 million on each of the 27th, 41st, 55th, 69th and 83rd day after the release.
- Q3 2027 results set row 23, the last: up to 1.9 billion on the second full trading day after the release or at the close of trading on 18 Nov 2027, day 365, whichever is earlier.
A preliminary or "flash" release does not count as the results release. The day counts in rows 7 to 11, 13 to 16 and 18 to 22 run from the results release itself. A day-count date that is not a trading day moves to the next trading day; day 180 and day 365 use the previous trading day's close.
Who is locked up, and for how long
About 15.5 billion shares, counted as Class A, are under lock-up or market-standoff agreements: the directors, the officers and the holders of substantially all of Anthropic's stock. Two terms apply.
- Up to 180 days
- Non-founder directors and officers, current and former employees and consultants, and certain stockholders with about 2.7 billion shares. The lock-up ends at the earlier of 6:00 AM ET on the second full trading day after the Q1 2027 results release and the close of trading on 17 May 2027. Non-founder directors, officers, employees and consultants could sell up to 10% of their holdings at 31 Oct 2026 from the first trading day.
- Up to 365 days
- The seven co-founders, and certain stockholders holding more than 0.5% of fully diluted shares before the IPO, with about 8 billion shares. The lock-up ends at the earlier of the second full trading day after the Q3 2027 results release and the close of trading on 18 Nov 2027. The co-founders may transfer up to 29% of their holdings at 31 Oct 2026 from the row 12 release. The shares of the holders above 0.5% are released in stages from day 27 (rows 2 to 22); only the remainder waits for row 23.
The table gives totals per date; the lock-up terms in the "Underwriting" section of the filing say which group each date applies to:
- Row 1: non-founder directors, officers, employees and consultants, 10% of their holdings.
- Rows 2 to 5 and 7 to 11: the 180-day stockholders with about 2.7 billion shares (6%, 6%, 7%, 7%, then 9.5% on each date) and the holders above 0.5% (1.8%, 1.8%, 2.1%, 2.1%, then 2.85% on each date).
- Row 6: a further 35% for non-founder directors, officers and employees, 12.5% for the 180-day stockholders and 3.75% for the holders above 0.5%.
- Row 12: the rest of the 180-day shares, plus 29% for the co-founders and 4.2% for the holders above 0.5%.
- Rows 13 to 22: the holders above 0.5% only: 5.6% on each of rows 13 to 16, 7.0% on row 17, then 6.3% on each of rows 18 to 22.
- Row 23: everything still locked.
What is not locked up
- The 980 million shares sold in the IPO. They trade freely; shares bought by affiliates are subject to Rule 144, and any shares that certain directors and their affiliated entities buy in the offering (they indicated interest in up to $305 million) are subject to the lock-up.
- The private placement. The 313,253,007 Class N shares sold in the concurrent private placement for about $26.0 billion are not under a lock-up or market standoff. They are restricted securities: they can be resold only under an effective registration statement or an exemption such as SEC Rule 144.
What can change the schedule
- Goldman Sachs and Morgan Stanley, the underwriters' representatives, may in their joint discretion release locked shares at any time, and in certain circumstances such a release triggers a pro rata release for certain other holders.
- A release makes shares eligible, not free of every limit: Rule 144 volume limits for affiliates and Anthropic's insider trading policy still apply.
- From day 195, 1 Jun 2027, certain holders may hedge up to 20% of their still-locked shares, up to about 719 million shares in total, as part of a pledge or financing arrangement.
Other dates after the IPO
- 18 Dec 2026
- Last day of the underwriters' option to buy up to 147 million more Class A shares from Anthropic at the IPO price; it runs for 30 days from the prospectus date. No exercise had been reported when this page was checked.
- 30 Nov 2026
- ANT's seventh trading day, which is also the Nasdaq-100 reconstitution reference date, the last trading day of November. The index methodology tests an IPO for fast entry at the end of its seventh trading day: its full market capitalization must rank within the top 40 of current constituents, and it must meet the other eligibility rules except seasoning. Because ANT's 15th trading day, 10 Dec 2026, falls in December and its seventh is on the reference date, an addition would come with the annual reconstitution, effective at the open on 21 Dec 2026; changes are announced after the close on 11 Dec 2026. Nasdaq had not announced an addition of ANT when this page was checked.
- Results dates
- Not announced. The FY2026 annual results release is the first one that matters here: it sets rows 6 to 11.
The ANT perp on release dates
xyz:ANT, the perpetual contract on one Anthropic share on Hyperliquid, trades around the clock, so it prints a price through every release date. At Sat, 21 Nov 2026 21:07:09 UTC it was at $89.97. The last column of the schedule fills in with the perp's close on each dated release once it has passed. What the perp did after each Nasdaq close is on the Anthropic IPO tracker. The perp is a contract settled in USDC: it gives no shares and is not itself subject to the lock-up.
Questions
- When does the Anthropic lock-up expire?
- There is no single date. The final prospectus releases locked shares in 23 stages from 19 Nov 2026. For everyone except the co-founders and certain holders of more than 0.5%, the lock-up ends at the earlier of 6:00 AM ET on the second full trading day after Anthropic's Q1 2027 results and the close of trading on 17 May 2027. For the co-founders and those holders, it ends at the earlier of the second full trading day after the Q3 2027 results and the close of trading on 18 Nov 2027, with staged releases before that.
- How many Anthropic shares unlock on 15 Dec 2026?
- Up to 303 million: up to 174 million Class A and up to 129 million Class N shares, per the prospectus. That equals 31% of the 980 million shares sold in the IPO. It is an upper limit on what becomes eligible for sale, not a count of shares that will be sold.
- Could Anthropic employees sell before the lock-up ends?
- In part. Non-founder directors, officers, and current and former employees and consultants could sell up to 10% of their holdings at 31 Oct 2026 from the first trading day, 19 Nov 2026: up to 315 million Class A shares in total. Up to a further 35% follows on the second full trading day after the FY2026 results (row 6), and the rest at row 12.
- Are the private placement shares locked up?
- No. The 313,253,007 Class N shares sold in the concurrent $26.0 billion private placement are not under a lock-up or market standoff. They are restricted securities: they can be resold only under an effective registration statement or an exemption such as SEC Rule 144.
Cite this page
Anthropic lock-up: 23 release dates in the final prospectus; next 15 Dec 2026, up to 303 million shares; day 180 is 17 May 2027, day 365 is 18 Nov 2027; about 15.5 billion shares locked. Checked 20 Nov 2026. Source: Perpys, https://perpys.com/ipo/anthropic/lock-up/
Dates and amounts are from the prospectus or counted from it; attribution "Source: Perpys" with a link is the only condition.
Sources
- SEC EDGAR: Anthropic, PBC final prospectus, form 424B4 (18 Nov 2026): Shares Eligible for Future Sale; Underwriting
- SEC EDGAR: Anthropic, PBC pricing term sheet, free writing prospectus (18 Nov 2026)
- Nasdaq: Nasdaq-100 Index methodology
- Nasdaq: US market holidays and early closes, 2026
- NYSE: holidays and trading hours, 2026 to 2028
Schedule and terms read in the filing on 20 Nov 2026. Day 180 and day 365 are counted from the prospectus date the way the filing counts day 27. Perp prices from Hyperliquid's public API. Data, not advice; see the disclaimer.